Reported Cases of End-Stage Kidney Disease - United States, 2000-2019 [0.03%]
2000-2019年美国终末期肾脏病报告病例数
Nilka Ríos Burrows,Alain Koyama,Meda E Pavkov
Nilka Ríos Burrows
End-stage kidney disease (ESKD) (kidney failure requiring dialysis or transplantation) is a costly and disabling condition that often results in premature death (1). During 2019, Medicare fee-for-service expenditures for ESKD were $37.3 bil...
Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021 [0.03%]
2001-2021年美国CDC资助 investigational new drug计划发放硝呋替莫治疗美洲锥虫病患者的特征及不良事件
Andrew Abbott,Susan P Montgomery,Rebecca J Chancey
Andrew Abbott
Chagas disease, or American trypanosomiasis, is caused by the parasite Trypanosoma cruzi. Chagas disease is endemic in rural areas of Latin America, but T. cruzi, triatomine vectors, infected mammalian reservoir hosts, and rare cases of aut...
Notes from the Field: Congenital Varicella Syndrome Case - Illinois, 2021 [0.03%]
简报：2021年伊利诺伊州先天性水痘综合征病例报告
Jessica Leung,Heather D Reid,Jodi Morgan et al.
Jessica Leung et al.
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022 [0.03%]
2021-22流感季节性流感疫苗效力的中期估算结果——美国，2022年2月
Jessie R Chung,Sara S Kim,Rebecca J Kondor et al.
Jessie R Chung et al.
In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months except when contraindicated (1). Currently available influenza vaccines are designed to protect against four influenza viruse...
SARS-CoV-2 Incidence in K-12 School Districts with Mask-Required Versus Mask-Optional Policies - Arkansas, August-October 2021 [0.03%]
2021年8—10月美国阿肯色州K-12学区要求佩戴口罩与不要求佩戴口罩的学校冠状病毒疾病2019发病率比较研究报告
Catherine V Donovan,Charles Rose,Kanna N Lewis et al.
Catherine V Donovan et al.
Masks are effective at limiting transmission of SARS-CoV-2, the virus that causes COVID-19 (1), but the impact of policies requiring masks in school settings has not been widely evaluated (2-4). During fall 2021, some school districts in Ar...
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022 [0.03%]
2021年11月～2022年1月美国5-11岁儿童的新冠疫苗供应和接种覆盖率
Christine Kim,Randy Yee,Roma Bhatkoti et al.
Christine Kim et al.
On October 29, 2021, the Pfizer-BioNTech pediatric COVID-19 vaccine received Emergency Use Authorization for children aged 5-11 years in the United States.† For a successful immunization program, both access to and uptake of the vaccine ar...
Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021 [0.03%]
评估登革病毒和SARS-CoV-2感染急性发热患者血清学交叉反应性——美国和波多黎各，2020年4月—2021年3月
Jorge Munoz-Jordan,Jaime Cardona,Manuela Beltrán et al.
Jorge Munoz-Jordan et al.
The diagnosis of dengue disease, caused by the dengue virus (DENV) (a flavivirus), often requires serologic testing during acute and early convalescent phases of the disease. Some symptoms of DENV infection, such as nonspecific fever, are s...
Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak - Tajikistan, 2020-2021 [0.03%]
现场笔记：准备使用II型新型口服脊髓灰质炎病毒疫苗应对2020-2021年塔吉克斯坦循环疫苗衍生脊髓灰质炎病毒疫情
Patrick O&#x;Connor,Shahin Huseynov,Carrie F Nielsen et al.
Patrick O&#x;Connor et al.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022 [0.03%]
2021年12月9日至2022年2月20日美国12-17岁人群新冠疫苗加强剂的安全监测报告
Anne M Hause,James Baggs,Paige Marquez et al.
Anne M Hause et al.
As of February 20, 2022, only BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine has been authorized for use in persons aged 12-17 years in the United States (1). The Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA)...